Acciones Sawai Pharmaceutical Co., Ltd. Japan Exchange
Acciones
4555
JP3323050009
Farmacéuticos
Ventas 2024 * | 194 mil M 1221,66 M 1142,9 M | Ventas 2025 * | 203 mil M 1282,59 M 1199,9 M | Capitalización | 261 mil M 1647,28 M 1541,08 M |
---|---|---|---|---|---|
Resultado Neto 2024 * | 19,79 mil M 125 M 117 M | Resultado Neto 2025 * | 19,91 mil M 126 M 118 M | VE / Ventas 2024 * | 1,53 x |
Deuda neta 2024 * | 34,69 mil M 219 M 205 M | Deuda neta 2025 * | 39,72 mil M 251 M 235 M | VE / Ventas 2025 * | 1,48 x |
P/E ratio 2024 * |
13,2
x | P/E ratio 2025 * |
13,1
x | Empleados | 3.393 |
Rendimiento 2024 * |
2,18 % | Rendimiento 2025 * |
2,31 % | Flotante | 0 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Mitsuo Sawai
CEO | Chief Executive Officer | 67 | 01/04/21 |
President | 66 | 01/04/21 | |
Toru Terashima
BRD | Director/Board Member | 64 | 01/04/21 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Mitsuo Sawai
CEO | Chief Executive Officer | 67 | 01/04/21 |
Kenzo Sawai
BRD | Director/Board Member | 55 | 01/04/21 |
Masatoshi Ohara
BRD | Director/Board Member | 73 | 01/04/21 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+25,83 % | 661 mil M | |
+27,00 % | 566 mil M | |
-6,76 % | 352 mil M | |
+20,34 % | 332 mil M | |
+3,00 % | 283 mil M | |
+13,09 % | 231 mil M | |
+5,46 % | 200 mil M | |
-9,61 % | 195 mil M | |
-6,26 % | 145 mil M |